tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eva Fortea Verdejo, 1 are a SELL (2.08%), 11 are a HOLD (22.92%), 36 are a BUY (75%).
Analyst Eva Fortea Verdejo, currently employed at WELLS FARGO, carries an average stock price target met ratio of 50.91% that have a potential upside of 35.22% achieved within 78 days.
Eva Fortea Verdejo’s has documented 95 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCAX, Bicara Therapeutics Common Stock at 12-Aug-2026.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for RCUS (ARCUS BIOSCIENCES) at 8/7/2025. The price target of $25 was fulfilled within 111 days with a profit of $15.72 (169.4%) receiving and performance score of 15.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Feb-2025
$33
$8.72 (35.91%)
$30
Hold Since 10-Nov-2025
$23
$-1.28 (-5.27%)
$16
Buy Since 06-Dec-2024
$42
$15.13 (56.31%)
$40
Buy Since 08-Oct-2024
$48
$21.13 (78.64%)
$48
Buy Since 09-Sep-2025
$22
$-4.87 (-18.12%)
Which stock is Eva Fortea Verdejo is most bullish on?
Which stock is Eva Fortea Verdejo is most reserved on?
What Year was the first public recommendation made by Eva Fortea Verdejo?
